3652 Vanderbilt Therapeutics (VT) CRS — Nashville, Tennessee

3652 Vanderbilt Therapeutics (VT) CRS is a clinical research site located in Nashville, Tennessee, United States 37204.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

3652 Vanderbilt Therapeutics (VT) CRS has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Acute HIV Infection, HIV-1 Infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

• Vanderbilt University Medical Center Diagnostic Lab- Site Number : 840049
• 10-20 Vanderbilt University Medical Center
• Monroe Carell Jr Children's Hospital at Vanderbilt
• Vanderbilt University Medical Center Clinical Research Center
• Vanderbilt University Medical Center /ID# 204231
• Vanderbilt University Medical Center-GCRC
• GI Clinical Research; Vanderbilt University Medical Center
• Vanderbilt University Medical Center /ID# 164607
• The Children's Hospital at TriStar Centennial Medical Center
• Vanderbilt University Medical Center; Multiple Sclerosis Center
• Monroe Carrell Jr Children's Hospital at Vanderbilt
• Vanderbilt University ASAP Research

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 3652 Vanderbilt Therapeutics (VT) CRS?

3652 Vanderbilt Therapeutics (VT) CRS has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 3652 Vanderbilt Therapeutics (VT) CRS conducted?

3652 Vanderbilt Therapeutics (VT) CRS has 4 clinical trials on record, with 1 currently active. Their work covers Acute HIV Infection, HIV-1 Infection.

Is 3652 Vanderbilt Therapeutics (VT) CRS accredited by Crixeo Clinical Trials?

3652 Vanderbilt Therapeutics (VT) CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 3652 Vanderbilt Therapeutics (VT) CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.